Pharma Journalist - Page 63 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

RyboDyn Joins Lilly Gateway Labs to Advance Immunotherapies Targeting Dark Proteome

Yeztugo Becomes First FDA-Approved HIV Prevention with 6-Month Protection

Actio Biosciences Raises $66M in Series B to Advance Genetics-Based Therapies

FNP-223 Receives FDA Fast Track Designation for Progressive Supranuclear Palsy

J&J Seeks FDA Approval of STELARA for Pediatric Crohn’s Disease

Draig Therapeutics Launches with $140M to Tackle Neuropsychiatric Disorders

Dyne’s DYNE-101 Earns FDA Breakthrough Status, Eyes Accelerated DM1 Approval

BioAegis Gets FDA Fast Track for ARDS Treatment with Gelsolin

Lilly to Acquire Verve Therapeutics for One-Time Cardiovascular Treatments

Lisata and GATC Health Expand Partnership for AI-Driven Drug Discovery